acute coronary syndrome

Telehealth clinical trial cuts hospital cardiac readmissions by 76%
Clinical Trials Arena
Thu, 04/11/24 - 11:48 am
SHL Telemedicine
telehealth
SmartHeart
acute coronary syndrome
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Yahoo/Benzinga
Tue, 03/7/23 - 10:16 am
Amarin
Vascepa
Vazkepa
acute coronary syndrome
clinical trials
AstraZeneca heart drug gets preferred status in U.S.
Yahoo/Reuters
Mon, 10/6/14 - 08:40 am
AstraZeneca
Brilinta
acute coronary syndrome
GSK starts phase III of coronary drug test
Reuters
Thu, 06/5/14 - 12:10 pm
GSK
losmapimod
acute coronary syndrome
FDA advisory panel rejects J&J drug for acute coronary syndrome
Reuters
Thu, 01/16/14 - 04:54 pm
JNJ
acute coronary syndrome
Xarelto
advisory panels
FDA
Losing the Battle and the War
Motley Fool
Sun, 06/24/12 - 11:20 am
JNJ
Xarelto
acute coronary syndrome
Losing the Battle and the War
Motley Fool
Sat, 06/23/12 - 12:13 pm
JNJ
Xarelto
acute coronary syndrome
Biotechs Have No Business in This Indication
Motley Fool
Sun, 03/18/12 - 11:23 am
Anthera
acute coronary syndrome
Anthera halts late-stage heart drug trial, shares tank
Reuters
Sat, 03/10/12 - 04:03 pm
Anthera
VISTA-16
acute coronary syndrome
Bayer, J&J clot drug to get fast FDA review for ACS
Reuters
Tue, 02/28/12 - 10:05 am
Bayer
FDA
JNJ
Xarelto
fast track
acute coronary syndrome
Merck's Vorapaxar Disappoints
Yahoo/Zacks
Sat, 11/19/11 - 12:13 pm
Merck
Vorapaxar
acute coronary syndrome
anticlotting
ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population
Forbes
Sun, 11/13/11 - 12:15 pm
rivaroxaban
Xarelto
acute coronary syndrome
anticoagulants
anti-platelets
TRACER: Novel Antiplatelet Vorapaxar Runs Into Trouble in ACS
Forbes
Sun, 11/13/11 - 12:11 pm
Vorapaxar
TRACER
acute coronary syndrome
anti-platelet
Merck
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Forbes
Fri, 09/30/11 - 09:26 am
rivaroxaban
JNJ
Xarelto
acute coronary syndrome
Bayer
Should You Buy It?: Anthera Pharmaceuticals
Motley Fool
Thu, 10/7/10 - 11:42 am
Anthera
acute coronary syndrome
lupus
FDA Pushes Out Brilinta Action Date
Yahoo/Zacks
Sat, 09/18/10 - 11:01 am
AstraZeneca
Brilinta
acute coronary syndrome
Plavix
Bristol-Myers Squibb
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Seeking Alpha
Sun, 06/27/10 - 11:04 am
Anthera
A-002
acute coronary syndrome
GSK
darapladib